NCT03423511View on ClinicalTrials.gov

Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries.

NANot yet recruitingINTERVENTIONAL
Enrollment

1,300

Participants

Timeline

Start Date

December 31, 2021

Primary Completion Date

June 1, 2023

Study Completion Date

June 1, 2027

Conditions
Coronary Artery Disease
Interventions
DEVICE

MiStent II coronary artery stent

Implantation of a coronary stent patient with stable and unstable coronary artery disease including non-ST-Elevated Myocardial Infarction

DEVICE

Xience or Promus coronary artery stents

Implantation of a coronary stent patient with stable and unstable coronary artery disease including non-ST-Elevated Myocardial Infarction

Sponsors
All Listed Sponsors
collaborator

Baim Institute for Clinical Research

OTHER

collaborator

North American Science Associates Inc.

UNKNOWN

collaborator

Yale Cardiovascular Research Group

OTHER

lead

Micell Technologies

INDUSTRY